Governance ASP Isotopes Inc.

ASPI

US00218A1051

Pharmaceuticals

End-of-day quote Nasdaq Other stock markets 2026-01-09			5-day change	1st Jan Change
7.510 ^USD	+16.61%		+33.39%	+40.37%

Dec. 30	ASX Midday Sector Update: Energy Stocks Climb, Real Estate Struggles	MT
Dec. 30	Renergen Securities Suspended From Quotation	MT

Executive Committee: ASP Isotopes Inc.

Manager

Positions heldSince

Robert Ainscow

50 year

Chief Executive Officer	2025-09-30
Chief Operating Officer	2024-03-31
Founder	2021-09-12

Jason Assad

Investor Relations Contact

Heather Kiessling

61 year

Director of Finance/CFO

2024-06-30

Hendrik Strydom

66 year

Chief Tech/Sci/R&D Officer

2021-12-31

Composition of the Board of Directors: ASP Isotopes Inc.

Director

CommitteesSince

Paul Mann

50 year

Audit Committee
Compensation Committee
Nominating Committee

Todd Wider

61 year

Compensation Committee	2024-05-01
Audit Committee Chair	2021-09-30
Governance Committee	2024-05-01
Nominating Committee	2024-05-01

Duncan Moore

67 year

Audit Committee	2021-09-30
Governance Committee	2021-09-30
Nominating Committee	2021-09-30
Compensation Committee Chair	2021-09-30

Rob Ryan

57 year

Audit Committee	2024-01-13
Governance Committee	2024-01-13
Nominating Committee	2024-01-13

Michael Gorley

39 year

Governance Committee	2023-10-18
Nominating Committee	2023-10-18

Sipho Maseko

57 year

Audit Committee

2024-08-28

Ralph Hunter

61 year

Director/Board Member

2025-09-07

Latest Appointments: ASP Isotopes Inc.

Jan. 07	ASP Isotopes Inc. completed the acquisition of Renergen Limited from Mazi Asset Management Ltd, Matc Investments Pty Ltd, CRT investments Pty. Ltd., Anchor Capital Ltd., Ivy Asset Management LLC, Ye Jia and others.	CI
Dec. 02	Asp Isotopes Inc. Announces That Paul Mann to Return from Temporary Leave of Absence as Executive Chairman	CI
Dec. 02	Asp Isotopes Inc. Announces Paul Mann to Return from Temporary Leave of Absence as Chief Executive Officer, Effective January 19, 2026	CI
Dec. 02	ASP Isotopes Says Paul Mann to Resume CEO Role in January	MT
Dec. 02	Asp Isotopes Inc. announces Paul Mann to return from temporary leave of absence as executive chairman and CEO	RE
25-09-29	ASP Isotopes Says CEO Paul Mann to Take Temporary Leave; Robert Ainscow Named Interim CEO	MT
25-09-29	Asp Isotopes appoints Paul Mann as executive chairman	RE

More news

Former Officers and Directors: ASP Isotopes Inc.

Insider

Positions held

SinceUntil

Joshua Donfeld

Director/Board Member

2021-09-30

2024-01-11

Sergey Vasnetsov

Director/Board Member

2021-09-30

2023-10-18

Age distribution of managers

Parity Men Women

Male	11
Female	1

Of which Executive Committee

Male	3
Female	1

Of which Directors

Male	7
Female	0

ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.

Employees

136

Sector

Pharmaceuticals

More about the company

Governance ASP Isotopes Inc.

Equities

ASPI

US00218A1051

Pharmaceuticals

Executive Committee: ASP Isotopes Inc.

Composition of the Board of Directors: ASP Isotopes Inc.

Latest Appointments: ASP Isotopes Inc.

Former Officers and Directors: ASP Isotopes Inc.

Age distribution of managers

Parity Men Women

Company Profile